These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 6779243)

  • 1. Cost-benefit analysis of a prenatal preventive programme against congenital syphilis.
    Stray-Pedersen B
    NIPH Ann; 1980 May; 3(1):57-66. PubMed ID: 6779243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Positive results from serologic screening for syphilis in pregnancy in the Amsterdam region, 1991-1995].
    Bont J; Cairo I; van Doornum GJ; Coutinho RA; Bleker OP
    Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2312-5. PubMed ID: 10589219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of maternal screening to prevent congenital syphilis.
    Stray-Pedersen B
    Sex Transm Dis; 1983; 10(4):167-72. PubMed ID: 6665662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital syphilis: an economic evaluation of a prevention program in China.
    Hong FC; Liu JB; Feng TJ; Liu XL; Pan P; Zhou H; Cai YM; Ling L; Huang XM; Zhang D; Zhang YJ; Zeegers MP
    Sex Transm Dis; 2010 Jan; 37(1):26-31. PubMed ID: 19734825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of on-site antenatal screening to prevent congenital syphilis in rural eastern Cape Province, Republic of South Africa.
    Blandford JM; Gift TL; Vasaikar S; Mwesigwa-Kayongo D; Dlali P; Bronzan RN
    Sex Transm Dis; 2007 Jul; 34(7 Suppl):S61-6. PubMed ID: 17308502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost-benefit analysis of California's mandatory premarital screening program for syphilis.
    Haskell RJ
    West J Med; 1984 Oct; 141(4):538-41. PubMed ID: 6438916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benefit of the serological screening program for syphilis in pregnant women in Amsterdam in the period 1985-1989].
    Bindels PJ; Postma MJ; Peerbooms PG; Coutinho RA; van den Hoek JA
    Ned Tijdschr Geneeskd; 1991 Jul; 135(29):1319-22. PubMed ID: 1907721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of preventive programmes against congenital toxoplasmosis.
    Stray-Pedersen B; Jenum P
    Scand J Infect Dis Suppl; 1992; 84():86-96. PubMed ID: 1290083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic and programmatic aspects of congenital syphilis prevention.
    Schmid G
    Bull World Health Organ; 2004 Jun; 82(6):402-9. PubMed ID: 15356931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is antenatal screening for syphilis worth while?
    Garland SM; Kelly VN
    Med J Aust; 1989 Oct; 151(7):368, 370, 372. PubMed ID: 2507883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevention and management of congenital syphilis: an overview and recommendations.
    Saloojee H; Velaphi S; Goga Y; Afadapa N; Steen R; Lincetto O
    Bull World Health Organ; 2004 Jun; 82(6):424-30. PubMed ID: 15356934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-benefit analysis of screening for congenital toxoplasmosis].
    Sagmeister M; Gessner U; Kind C; Horisberger B
    Schweiz Med Wochenschr Suppl; 1995; 65():103S-112S. PubMed ID: 7716447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
    Kumar M; Birch S; Maturana A; Gafni A
    Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand.
    Thaineua V; Sirinirund P; Tanbanjong A; Lallemant M; Soucat A; Lamboray JL
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):429-42. PubMed ID: 10437936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
    Goldstein JA; Winston FK; Kallan MJ; Branas CC; Schwartz JS
    Ambul Pediatr; 2008; 8(1):58-65. PubMed ID: 18191783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syphilis-associated perinatal and infant mortality in rural Malawi.
    McDermott J; Steketee R; Larsen S; Wirima J
    Bull World Health Organ; 1993; 71(6):773-80. PubMed ID: 8313495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antenatal syphilis screening in sub-Saharan Africa: lessons learned from Tanzania.
    Watson-Jones D; Oliff M; Terris-Prestholt F; Changalucha J; Gumodoka B; Mayaud P; Semakafu AM; Kumaranayake L; Gavyole A; Mabey D; Hayes R
    Trop Med Int Health; 2005 Sep; 10(9):934-43. PubMed ID: 16135202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism.
    Geelhoed EA; Lewis B; Hounsome D; O'leary P
    J Paediatr Child Health; 2005 Nov; 41(11):575-9. PubMed ID: 16398841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A cost-benefit evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism].
    Gu X; Wang J; Ye J; Cheng X
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):147-9. PubMed ID: 11860921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.